1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Philadelphia Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) matching grant is sponsored by City of Philadelphia, Department of Commerce. This city-led matching grant program supports Philadelphia-based life sciences companies that have received a federal SBIR/STTR grant. It provides customized technical and business assistance to advance company growth and commercialization.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
City provides $450,000 SBIR / STTR matching grants to support life sciences commercialization in Philadelphia | Department of Commerce | City of Philadelphia You are using an outdated browser. Please upgrade your browser to improve your experience. If you can't switch browsers, turn off compatibility mode.
City provides $450,000 SBIR / STTR matching grants to support life sciences commercialization in Philadelphia Great news! The Philadelphia Department of Commerce , Office of Business Development has awarded $450,000 in SBIR/STTR Matching Grants to 21 life sciences companies , marking Pennsylvania’s first City-led matching grant program of its kind.
These awards support life sciences companies that received Phase 1 or Phase 2 of the Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grants from the federal government in 2022 or later. These funds are to support the commercialization of each life sciences companies based on their SBIR/STTR research.
The University City Science Center serves as the City’s implementation partner working directly with each awardee to deploy funds with suite of services in alignment with their commercialization goals. This approach helps ensure that support is tailored to each company’s needs and focused on accelerating their progress toward real-world application.
The life sciences companies that received SBIR / STTR matching grants from the Department of Commerce are: BioLattice Ophthalmics, Inc . BriaCell Therapeutics Corp. Linnaeus Therapeutics, Inc. Questions? Email Rebecca.
Grant@phila. gov . Philadelphia’s life sciences and biotechnology sector continues to be a driver of innovation and economic growth.
These companies are advancing therapeutic discoveries, developing new technologies, and creating skills-based job opportunities for Philadelphians. These awards from the Department of Commerce represent a meaningful step forward for Philadelphia’s innovation economy by supporting local companies while laying the groundwork for long-term growth, scientific advancement, and improved outcomes for patients.
Learn more about the program Birth, marriage & life events Business & self-employment Cars, parking & transportation Diversity, inclusion, accessibility & immigration Payments, assistance & taxes Permits, violations & licenses Safety & emergency preparedness Streets, sidewalks & alleys Trash, recycling & city upkeep Trees, parks & the environment Zoning, planning & development
According to the current listing, eligibility includes: Life sciences companies located in Philadelphia that have received a Phase I or Phase II federal SBIR/STTR grant from the federal government in 2022 or later. Confirm the full requirements in the official notice before applying.
The current listing shows up to $20,000 for Phase I services; up to $50,000 for Phase II services. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Philadelphia Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) matching grant is funded by City of Philadelphia, Department of Commerce. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
In January 2026, DOE Policy Flash PF-2026-30 wiped out every 15% and 10% indirect cost cap the administration had imposed in 2025 — because H.R. 6938 ordered it to. The same law froze indirect policy at NSF, Commerce and NASA. But OMB's sweeping new grants rule quietly reopens the fight through the back door. Here is what changed, what money recipients can claw back, and how to protect your indirect recovery going forward.
Read articleThe William Penn Foundation's May 2026 docket distributed $57.2M across 128 grants, with 41 percent flowing to Children and Families. The breakdown reveals which Philadelphia nonprofit categories are gaining institutional traction and which are being asked to make harder cases.
Read articleThe Commerce Department's August 2025 march-in proceeding against Harvard is the first invocation of an authority that sat dormant for 45 years. The policy precedent reaches every Bayh-Dole grantee — and the operational compliance gap is wider than most institutions realize.
Read article